ROYAL BANK OF CANADA - VIRACTA THERAPEUTICS INC ownership

VIRACTA THERAPEUTICS INC's ticker is VIRX and the CUSIP is 92765F108. A total of 50 filers reported holding VIRACTA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.67 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of VIRACTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,0001,501
+407.1%
0.00%
Q2 2023$0
-100.0%
296
-90.2%
0.00%
Q1 2023$5,0003,007
+42857.1%
0.00%
Q4 2022$0
-100.0%
7
-99.7%
0.00%
Q1 2022$11,000
-97.8%
2,227
-98.4%
0.00%
Q4 2021$502,000
-65.7%
137,607
-24.5%
0.00%
Q3 2021$1,462,000
-33.7%
182,319
-6.3%
0.00%
-100.0%
Q2 2021$2,206,000
+11510.5%
194,526
+9426.2%
0.00%
Q1 2021$19,0002,0420.00%
Other shareholders
VIRACTA THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Aisling Capital Management LP 288,571$421,3140.28%
BVF INC/IL 3,614,662$5,277,4070.22%
Samsara BioCapital, LLC 689,709$1,006,9750.22%
Rubric Capital Management LP 1,330,983$1,943,2350.08%
HAMILTON LANE ADVISORS LLC 35,791$520.02%
MAI Capital Management 426,916$623,2970.01%
Jasper Ridge Partners, L.P. 92,939$135,6910.01%
BOURGEON CAPITAL MANAGEMENT LLC 17,500$25,5500.01%
RP Management, LLC 3,700$5,4020.01%
Laurion Capital Management LP 698,000$1,019,0800.01%
View complete list of VIRACTA THERAPEUTICS INC shareholders